menu
    • menu
    [{"orgOrder":0,"company":"LambdaVision","sponsor":"NASA","pharmaFlowCategory":"D","therapeuticArea":"Genetic Disease","country":"U.S.A","productType":"Protein","year":"2025","type":"Funding","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Genetic Disease","graph2":"Preclinical","graph3":"LambdaVision","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Implant","sponsorNew":"LambdaVision \/ NASA","highestDevelopmentStatusID":"4","companyTruncated":"LambdaVision \/ NASA"},{"orgOrder":0,"company":"LambdaVision","sponsor":"Seven Seven Six | Aurelia Foundry Fund | Seraphim Space","pharmaFlowCategory":"D","therapeuticArea":"Genetic Disease","country":"U.S.A","productType":"Protein","year":"2025","type":"Financing","leadProduct":"Bacteriorhodopsin","moa":"Undisclosed","graph1":"Genetic Disease","graph2":"Preclinical","graph3":"LambdaVision","amount2":0.01,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Genetic Disease","amount2New":0.01,"dosageForm":"Undisclosed","sponsorNew":"LambdaVision \/ Seven Seven Six | Aurelia Foundry Fund | Seraphim Space","highestDevelopmentStatusID":"4","companyTruncated":"LambdaVision \/ Seven Seven Six | Aurelia Foundry Fund | Seraphim Space"}]

    Find Clinical Drug Pipeline Developments & Deals by LambdaVision

    Menu

    LambdaVision

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            LambdaVision

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            LambdaVision

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Bacteriorhodopsin

                            Therapeutic Area : Genetic Disease

                            Study Phase : Preclinical

                            Sponsor : Seven Seven Six | Aurelia Foundry Fund | Seraphim Space

                            Deal Size : $7.0 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            Lambdavision Raises $7M Seed Round for Space-Based Blindness Treatment

                            Details : The financing will support the development of Bacteriorhodopsin, a protein, for retinal degenerative diseases.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Undisclosed

                            November 05, 2025

                            Lead Product(s) : Bacteriorhodopsin

                            Therapeutic Area : Genetic Disease

                            Highest Development Status : Preclinical

                            Sponsor : Seven Seven Six | Aurelia Foundry Fund | Seraphim Space

                            Deal Size : $7.0 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            LambdaVision

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            LambdaVision

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Genetic Disease

                            Study Phase : Preclinical

                            Sponsor : NASA

                            Deal Size : Undisclosed

                            Deal Type : Funding

                            DEALS_DEV arrow-down

                            LambdaVision Secures NASA Phase 2 InSPA Award to Advance Manufacturing Efforts

                            Details : This NASA award will enable LambdaVision to further develop layer-by-layer manufacturing processes to support artificial retina production.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Undisclosed

                            September 04, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Genetic Disease

                            Highest Development Status : Preclinical

                            Sponsor : NASA

                            Deal Size : Undisclosed

                            Deal Type : Funding

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth